Association Between Merkel Cell Polyomavirus and Merkel Cell Carcinoma

Merkel Cell Carcinoma: A Multidisciplinary Approach

Volumn , Issue , 2010, Pages 55-79

  Rollison, Dana E ^a   Becker, Jürgen C ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955171412     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781848163140_0003     Document Type: Chapter

References (83)

1. Steben M., Duarte-Franco E. (2007). Human papillomavirus infection: Epidemiology and pathophysiology. Gynecol Oncol 107: S2–S5.
2. Gillison M.L. (2004). Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 31: 744–754, 2004.
3. Kremsdorf D., Soussan P., Paterlini-Brechot P., Brechot C. (2006). Hepatitis B virus-related hepatocellular carcinoma: Paradigms for viral-related human carcinogenesis. Oncogene 25: 3823–3833.
4. Matsuoka M., Jeang K.T. (2007). Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7: 270–280.
5. Kutok J.L., Wang F. (2006). Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 1: 375–404.
6. Chang Y., Cesarman E., Pessin M.S., et al. (1994). Identification of herpesvirus- like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266: 1865–1869.
7. Pagano J.S., Blaser M., Buendia M.A., et al. (2004). Infectious agents and cancer: Criteria for a causal relation. Semin Cancer Biol 14: 453–471.
8. Engels E.A., Biggar R.J., Hall H.I., et al. (2008). Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123: 187–194.
9. Adami J., Gabel H., Lindelof B., et al. (2003). Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 89: 1221–1227.
10. Miller R.W., Rabkin C.S. (1999). Merkel cell carcinoma and melanoma: Etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 8: 153–158.
11. Penn I., First M.R. (1999). Merkel’s cell carcinoma in organ recipients: Report of 41 cases. Transplantation 68: 1717–1721.
12. Howard R.A., Dores G.M., Curtis R.E., et al. (2006). Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol Biomarkers Prev 15: 1545–1549.
13. Engels E.A., Frisch M., Goedert J.J., et al. (2002). Merkel cell carcinoma and HIV infection. Lancet 359: 497–498.
14. Agelli M., Clegg L.X. (2003). Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 49: 832–841.
15. Hodgson N.C. (2005). Merkel cell carcinoma: Changing incidence trends. J Surg Oncol 89: 1–4.
16. Vortmeyer A.O., Merino M.J., Boni R., et al. (1998). Genetic changes associated with primary Merkel cell carcinoma. Am J Clin Pathol 109: 565–570.
17. Kripke M.L., Fisher M.S. (1976). Immunologic parameters of ultraviolet carcinogenesis. J Natl Cancer Inst 57: 211–215.
18. Greene M.I., Sy M.S., Kripke M., Benacerraf B. (1979). Impairment of antigen-presenting cell function by ultraviolet radiation. Proc Natl Acad Sci USA 76: 6591–6595.
19. Miyauchi-Hashimoto H., Tanaka K., Horio T. (1996). Enhanced inflammation and immunosuppression by ultraviolet radiation in xeroderma pigmentosum group A (XPA) model mice. J Invest Dermatol 107: 343–348.
20. Kolgen W., Both H., van Weelden H., et al. (2002). Epidermal Langerhans cell depletion after artificial ultraviolet B irradiation of human skin in vivo: Apoptosis versus migration. J Invest Dermatol 118: 812–817.
21. Cooper K.D., Oberhelman L., Hamilton T.A., et al. (1992). UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: Relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci USA 89: 8497–8501.
22. Ullrich S.E., Nghiem D.X., Khaskina P. (2007). Suppression of an established immune response by UVA— a critical role for mast cells. Photochem Photobiol 83: 1095–1100.
23. Feng H., Shuda M., Chang Y., Moore P.S. (2008). Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319: 1096–1100.
24. Allander T., Andreasson K., Gupta S., et al. (2007). Identification of a third human polyomavirus. J Virol 81: 4130–4136.
25. Gaynor A.M., Nissen M.D., Whiley D.M., et al. (2007). Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 3: E64.
26. Padgett B.L., Walker D.L., ZuRhein G.M., et al. (1971). Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1: 1257–1260.
27. Gardner S.D., Field A.M., Coleman D.V., Hulme B. (1971). New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1(7712): 1253–1257.
28. Rollison D.E., Engels E.A., Halsey N.A., et al. (2006). Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 15: 543–550.
29. Shah K. (1996). Polyomaviruses. In: Fields B., Knipe D., Howley P. (eds.) Field’s Virology, pp. 2027–2043, Lippincott-Raven, Philadelphia.
30. Carter J.J., Madeleine M.M., Wipf G.C., et al. (2003). Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst 95: 1522–1530.
31. Shah K.V. (2007). SV40 and human cancer: A review of recent data. Int J Cancer 120: 215–223.
32. zur Hausen H. (2008). Novel human polyomaviruses — re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 123: 247–250.
33. Major E.O., Mourrain P., Cummins C. (1984). JC virus-induced owl monkey glioblastoma cells in culture: Biological properties associated with the viral early gene product. Virology 136: 359–367.
34. Shah K.V., Daniel R.W., Strandberg J.D. (1975). Sarcoma in a hamster inoculated with BK virus, a human papovavirus. J Natl Cancer Inst 54: 945–950.
35. Caracciolo V., Reiss K., Khalili K., et al. (2006). Role of the interaction between large T antigen and Rb family members in the oncogenicity of JC virus. Oncogene 25: 5294–5301.
36. Moens U., Van G.M., Johannessen M. (2007). Oncogenic potentials of the human polyomavirus regulatory proteins. Cell Mol Life Sci 64: 1656–1678.
37. Gan D.D., Khalili K. (2004). Interaction between JCV large T-antigen and beta-catenin. Oncogene 23: 483–490.
38. Reiss K., Khalili K., Giordano A., Trojanek J. (2006). JC virus large T-antigen and IGF-I signaling system merge to affect DNA repair and genomic integrity. J Cell Physiol 206: 295–300.
39. Trojanek J., Croul S., Ho T., et al. (2006). T-antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS-1 and Rad51. J Cell Physiol 206: 35–46.
40. Bergsagel D.J., Finegold M.J., Butel J.S., et al. (1992). DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 326: 988–993.
41. Caldarelli-Stefano R., Boldorini R., Monga G., et al. (2000). JC virus in human glial-derived tumors. Hum Pathol 31: 394–395.
42. Carbone M., Pass H.I., Rizzo P., et al. (1994). Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9: 1781–1790.
43. Corallini A., Pagnan M., Viadana P., et al. (1987). Association of BK virus with human brain tumors and tumors of pancreatic islets. Int J Cancer 39: 60–67.
44. Del Valle L., Gordon J., Assimakopoulou M., et al. (2001). Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Res 61: 4287–4293.
45. Dorries K., Loeber G., Meixensberger J. (1987). Association of polyomaviruses JC, SV40, and BK with human brain tumors. Virology 160: 268–270.
46. Shivapurkar N., Wiethege T., Wistuba I.I., et al. (1999). Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem 76: 181–188.
47. Vilchez R.A., Butel J.S. (2003). SV40 in human brain cancers and non- Hodgkin’s lymphoma. Oncogene 22: 5164–5172.
48. Weggen S., Bayer T.A., von Deimling A., et al. (2000). Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol 10: 85–92.
49. Viscid R.P., Shah K.V. (2008). Cancer. A skin cancer virus? Science 319: 1049–1050.
50. Engels E.A., Viscidi R.P., Galloway D.A., et al. (2004). Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst 96: 1368–1374.
51. Engels E.A., Rollison D.E., Hartge P., et al. (2005). Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma. Int J Cancer 117: 1013–1019.
52. Rollison D.E., Helzlsouer K.J., Alberg A.J., et al. (2003). Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol Biomarkers Prev 12: 460–463.
53. Rollison D.E., Helzlsouer K.J., Halsey N.A., et al. (2005). Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort. Cancer Epidemiol Biomarkers Prev 14: 1448–1452.
54. Shuda M., Feng H., Kwun H.J., et al. (2008). T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA 105: 16272–16277.
55. Kassem A., Schopflin A., Diaz C., et al. (2008). Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res 68: 5009–5013.
56. Becker J.C., Houben R., Ugurel S., et al. (2008). MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol 129: 248–250.
57. Bhatia K., Goedert J.J., Modali R., et al. (2009). Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer [Epub ahead of print].
58. Duncavage E.J., Zehnbauer B.A., Pfeifer J.D. (2009). Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma. Mod Pathol 22: 516–521.
59. Foulongne V., Kluger N., Dereure O., et al. (2008). Merkel cell polyomavirus and Merkel cell carcinoma, France. Emerg Infect Dis 14: 1491–1493.
60. Garneski K.M., Warcola A.H., Feng Q., et al. (2008). Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol 129: 246–248.
61. Helmbold P., Lahtz C., Enk A., et al. (2009). Frequent occurrence of RASSF1A promoter hypermethylation and Merkel cell polyomavirus in Merkel cell carcinoma. Mol Carcinog 48: 903–909.
62. Kean J.M., Rao S., Wang M., Garcea R.L. (2009). Seroepidemiology of human polyomaviruses PLoS Pathog 5: E1000363.
63. Sastre-Garau X., Peter M., Avril M.F., et al. (2009). Merkel cell carcinoma of the skin: Pathological and molecular evidence for a causative role of MCPyV in oncogenesis. J Pathol 218: 48–56.
64. Sihto H., Kukko H., Koljonen V., et al. (2009). Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 101: 938–945.
65. Touze A., Gaitan J., Maruani A., et al. (2009). Merkel cell polyomavirus strains in patients with Merkel cell carcinoma. Emerg Infect Dis 15: 960–962.
66. Varga E., Kiss M., Szabo K., Kemeny L. (2009). Detection of Merkel cell polyomavirus DNA in Merkel cell carcinomas. Br J Dermatol 161: 930–932.
67. Wetzels C.T., Hoefnagel J.G., Bakkers J.M., et al. (2009). Ultrastructural proof of polyomavirus in Merkel cell carcinoma tumour cells and its absence in small cell carcinoma of the lung. PLoS One 4: E4958.
68. Ridd K., Yu S., Bastian B.C. (2009). The presence of polyomavirus in nonmelanoma skin cancer in organ transplant recipients is rare. J Invest Dermatol 129: 250–252.
69. Kassem A., Technau K., Kurz A.K., et al. (2009). Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer 125: 356–361.
70. Dworkin A.M., Tseng S.Y., Allain D.C., et al. (2009). Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. J Invest Dermatol 129: 2868–2874.
71. Giraud G., Ramqvist T., Ragnarsson-Olding B., Dalianis T. (2008). DNA from BK virus and JC virus and from KI, WU, and MC polyomaviruses as well as from simian virus 40 is not detected in non-UV-light-associated primary malignant melanomas of mucous membranes. J Clin Microbiol 46: 3595–3598.
72. Brenner B., Sulkes A., Rakowsky E., et al. (2001). Second neoplasms in patients with Merkel cell carcinoma. Cancer 91: 1358–1362.
73. Shuda M., Arora R., Kwun H.J., et al. (2009). Human Merkel cell polyomavirus infection I. MCPyV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 125: 1243–1249.
74. Helmbold P., Lahtz C., Herpel E., et al. (2009). Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer. Eur J Cancer 45: 2207–2211.
75. Bluemn E.G., Paulson K.G., Higgins E.E., et al. (2009). Merkel cell polyomavirus is not detected in prostate cancers, surrounding stroma, or benign prostate controls. J Clin Virol 44: 164–166.
76. Sharp C.P., Norja P., Anthony I., et al. (2009). Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals. J Infect Dis 199: 398–404.
77. Monaco M.C., Jensen P.N., Hou J., et al. (1998). Detection of JC virus DNA in human tonsil tissue: Evidence for site of initial viral infection. J Virol 72: 9918–9923.
78. Ren L., Gonzalez R., Xie Z., et al. (2008). WU and KI polyomavirus present in the respiratory tract of children, but not in immunocompetent adults. J Clin Virol 43: 330–333.
79. Goh S., Lindau C., Tiveljung-Lindell A., Allander T. (2009). Merkel cell polyomavirus in respiratory tract secretions. Emerg Infect Dis 15: 489–491.
80. Bialasiewicz S., Lambert S.B., Whiley D.M., et al. (2009). Merkel cell polyomavirus DNA in respiratory specimens from children and adults. Emerg Infect Dis 15: 492–494.
81. Kantola K., Sadeghi M., Lahtinen A., et al. (2009). Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: Implications for respiratory transmission and latency. J Clin Virol 5: 292–295.
82. Tolstov Y.L., Pastrana D.V., Feng H., et al. (2009). Human Merkel cell polyomavirus infection II. MCPyV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 125: 1250–1256.
83. Shah K.V., Rollison D.E. (2001). Investigation of the SV40 — human cancer association: Look for the full signature of the virus. Dis Markers 17: 159–161.